Before Johns Hopkins Hospital in Baltimore implemented a blood clot risk program in Epic, female patients at the organization were 50% more likely than men to miss out on proper VTE prophylaxis medication. This disparity points to a wider trend in healthcare for women to receive less intensive and timely treatments than men. With decision support in Epic, Johns Hopkins made care for both women and men more consistent.
When a patient is admitted to Johns Hopkins, her physician completes a blood clot risk checklist in Epic, which recommends a treatment based on the patient’s risk factors. As a result of this program, the prophylaxis prescription rate among patients at risk for blood clots increased from an average of 65.6% to 90.1%, which brought preventable blood clots down to zero.
Read more here.